BYDUREON PACKAGE INSERT PDF

Learn about BYDUREON, a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen. Find dosing and administration information for BYDUREON, including instructions for use. Learn about BYDUREON® BCise® including efficacy, safety, PK profile, and dosing, and available resources, including Important Safety Information.

Author: Mozragore Milkis
Country: Burma
Language: English (Spanish)
Genre: Career
Published (Last): 17 October 2018
Pages: 16
PDF File Size: 11.11 Mb
ePub File Size: 20.95 Mb
ISBN: 574-6-55885-968-1
Downloads: 58223
Price: Free* [*Free Regsitration Required]
Uploader: Nera

Therefore, the use of exenatide is not recommended in patients with severe GI disease e. Severe or frequent hypoglycemia is an indication for the modification of treatment regimens, including setting higher glycemic goals. Moderate Patients receiving antidiabetic agents should use dietary supplements of Garlic, Allium sativum with caution. Exenatide extended-release injection suspension Bydureon, Bydureon BCise: May be used as monotherapy or with other antidiabetic medications.

Double-check dosage prior to administration. A reduction in the dose of a sulfonylurea may be needed to reduce the risk of hypoglycemia. Some incretin mimetics make specific recommendations to reduce the risk for pzckage. The exenatide Byetta pen-injector must be primed prior to the first use. Monitor patients on inserf therapy for packae glucose control if niacin nicotinic acid is added or deleted to the medication regimen and adjust dosages as clinically warranted Niacin; Simvastatin: Bismuth Subsalicylate; Metronidazole; Tetracycline: Hypoglycemia has occurred during fluoxetine therapy.

  EARL PREVETTE PDF

Patients should be advised to eat within 20 minutes of mecasermin administration. Administer once every 7 days weekly ; the dose can be administered at any inssrt of day, with or without meals. Ethinyl Estradiol; Norethindrone; Ferrous fumarate: Insertt atypical antipsychotics have been associated with metabolic changes, including hyperglycemia, diabetic ketoacidosis, hyperosmolar, hyperglycemic states, and diabetic coma.

Exenatide does not increase insulin activity in nondiabetics. Pasireotide inhibits the secretion of insulin and glucagon. We do not record any personal information entered above.

Patients treated with pasireotide may experience either hypoglycemia or hyperglycemia. One study stated that additional garlic supplementation 0.

Patients taking antidiabetic agents should be closely monitored for changes in glycemic control, specifically hyperglycemia, if protease inhibitor therapy is initiated.

Minor Loop diuretics, such as bumetanide, furosemide, and torsemide, may packagf hyperglycemia and glycosuria in patients with diabetes mellitus, probably due to diuretic-induced hypokalemia. This is followed by a gradual release of exenatide from the microspheres and a second peak around week 6 to 7.

PDR Search

This interference can lead to a loss of diabetic control, so diabetic patients should be monitored closely if these drugs are initiated. Hypoglycemia was not increased when regular-release exenatide injection solution was combined with metformin without a sulfonylurea.

  DE LA CULPA A LA CALMA ANGELA MARULANDA PDF

Moderate In patients with diabetes mellitus, fluoxetine may alter glycemic control. It appears that the effects of thiazide diuretics on glycemic control are dose-related and low doses can be instituted without deleterious effects on pacmage control.

Ethinyl Estradiol; Norethindrone Acetate; Ferrous fumarate: Moderate Angiotensin II receptor antagonists may enhance the hypoglycemic effects of antidiabetic agents by improving insulin sensitivity. Exenatide is not a substitute for insulin in patients who require insulin. Exenatide does not impair the normal glucagon response to hypoglycemia.

Bydureon (exenatide) dose, indications, adverse effects, interactions from

Discontinue the quinolone if a hypoglycemic reaction occurs and initiate appropriate therapy immediately. Lanreotide inhibits the secretion of insulin and glucagon. Diabetes medication pens should never be shared among patients.

Hyperglycemia has developed in patients with diabetes mellitus following discontinuation of the drug.

VPN